Home / Resources / Adoptive Cell Therapy

Adoptive Cell Therapy

Infographic
Clinical
Adoptive_Cell_Therapy

In 2021, adoptive cell therapy (ACT) research reached a new high. See other ACT trends over the past five years.

Related products
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
Discover the ultimate clinical trial benchmarking tool
Healthcare professional monitoring and analyzing R and D trends.
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence

Related resources

ASGCT Citeline Q3 2023 Report_resource-card-thumbnail
OCT 01, 2023
Report
Commercial

Gene, Cell, + RNA Therapy Landscape Q3 2023 Report

Q3 2023 saw 3,866 therapies in development; 53% of those were gene therapies, 25% RNA therapies, and 22% non-genetically modified cell therapies.

Clinical-resource-ISCT Report_resource-card-thumbnail
JUN 01, 2023
Report
Clinical

Cell and Gene Therapy Global Regulatory Report

The first Cell and Gene Therapy Regulatory Report from Citeline and ISCT provides a global overview of the cell and gene therapy landscape.

ESMO congress event logo held in Madrid 2023.
OCT 01, 2023
Article
Clinical

ESMO 2023 Insights

In this overview, we look at the clinical trial landscape for trials that had data presented at ESMO 2023.

View All Resources
Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.